EFFICACY OF INTRATYMPANIC OTO-104 FOR THE TREATMENT OF MÉNIÈRE'S DISEASE: THE OUTCOME OF THREE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES

Otol Neurotol. 2024 Oct 1;45(9):1087-1088. doi: 10.1097/MAO.0000000000004289. Epub 2024 Aug 26.
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Double-Blind Method
  • Female
  • Humans
  • Injection, Intratympanic*
  • Male
  • Meniere Disease* / drug therapy
  • Middle Aged
  • Treatment Outcome